PUBM · PubMatic, Inc.

The thesis

PubMatic's year-over-year revenue recovery, new connected-TV and agentic-advertising wins and a favourable Google remedy ruling hold the shares near their 52-week high. The Q3 2026 report, estimated for 5 November to 9 November 2026, decides the case: revenue has to land at or above the $75 million floor the company guided to on 6 August 2026.

The shares closed at $18.68 on 8 October 2026, 2.6% below the $19.18 52-week closing high of 1 October 2026, on adjusted daily closes. They are up 37.7% over three months, and the 14-day relative strength index (RSI) stands at 62.5. Since the previous update the price has recovered from the $18.35 close of 6 October 2026.

The narrative is maturing: the recovery story is well known, and no new company financials have arrived since the 6 August 2026 report. Since then, attention has come from analyst actions on 18 September 2026 and 24 September 2026 and from the Sony partnership announced on 6 October 2026. MarketBeat's consensus target is $19.73, about a dollar above the last close, so further gains depend on the reported numbers.

Bullish and bearish views on PubMatic, Inc.

The bull case on PubMatic, Inc. (PUBM), in brief: Reported growth supports the recovery. The bear case: Guidance points to a smaller Q3.

Bull case

• Reported growth supports the recovery. On 6 August 2026 PubMatic reported Q2 2026 revenue of $78.593 million, up 11% year over year, against a $68.95 million consensus estimate recorded by MarketBeat.
• Sony adds premium connected-TV supply. On 6 October 2026 PubMatic announced that Sony Pictures Entertainment chose it as preferred programmatic advertising partner for Live TV on PS5. Advanced Television reported that the ad-supported US service carries more than 100 live channels.
• Agentic campaigns are scaling from a small base of activity. On the 6 August 2026 call, management reported 80 Agentic OS campaigns in Q2, up from 30 in Q1, and 4,000 AI-powered deals, up from 1,000. ExchangeWire reported on 5 October 2026 a six-market agentic luxury campaign in Southeast Asia run on PubMatic's AgenticOS.
• The Google remedy opens auctions to rivals. AdExchanger reported on 2 September 2026 that Judge Leonie Brinkema ordered Google to share real-time bid data from its ad exchange (AdX) with rival ad servers and to end its "first look" and "last look" privileges.
• Analyst targets rose in September. B. Riley raised its target to $21 from $17 on 18 September 2026, and Craig-Hallum started coverage at Buy with a $24 target on 24 September 2026. MarketBeat counted 11 Buy, 1 Hold and 1 Sell ratings in early October 2026.

Bear case

• Guidance points to a smaller Q3. The $75–77 million Q3 revenue outlook given on 6 August 2026 sits below the $78.593 million reported for Q2. The recovery is a year-over-year story; quarter over quarter, revenue is guided lower.
• The price sits near the consensus target. The $18.68 close on 8 October 2026 is just under MarketBeat's $19.73 consensus target. Higher prices need new target increases or a Q3 beat.
• the company tied the October sales to tax withholding on vested equity.
• Google's exchange stays intact. The 2 September 2026 ruling rejected divesting AdX. The remedies change auction conduct, and the size of any share shift to independent exchanges has not been reported.
• The company is still loss-making on a GAAP basis. Q2 2026 produced a $1.2 million net loss, and MarketBeat shows a forecast full-year loss of $0.09 per share.

Price setup

The shares closed at $18.68 on 8 October 2026, against a $19.18 52-week closing high set on 1 October 2026. MarketBeat put the 50-day moving average at $16.60 and the 200-day at $12.79 in early October 2026, so the price trades well above both rising averages.

The August 2026 high of $17.78 is the nearest prior peak below the current price. A move back under it would erase the gains made since the Google ruling and the September target raises. The $15.20 level sits under the 50-day average and marks where the post-earnings advance would be largely undone.

An RSI of 62.5 on 8 October 2026 shows strong momentum without an extreme reading. The main crowding signals are the gap above the 200-day average, steady insider sales near the high, and an earnings report about four weeks away.

Catalysts, next 30 days

• ~5 November 2026, est. Q3 2026 results. Earnings calendars list 5 November 2026 after the close, and some show 9 November 2026; the company had not confirmed the date as of 9 October 2026. The report is measured against $75–77 million revenue and $17–19 million adjusted EBITDA guidance. The Q4 outlook shows whether revenue returns above the $78.593 million reported for Q2, and the call is the first chance for management to quantify any effect of the Google remedies.

What would change the view

The case breaks if Q3 2026 revenue comes in below the $75 million floor set on 6 August 2026. It also weakens if the Q4 outlook implies year-over-year growth slowing from the 11% reported for Q2, or if management reports no measurable change in auction access from the 2 September 2026 remedies.

On price, a weekly close below $15.20 would put the shares under their 50-day average and well below the $17.78 August high. That would show the advance since August has unwound before new operating data arrives. A Q3 guidance cut or the loss of a named connected-TV partner would break the case regardless of price.

What it trades with

PubMatic trades with other independent ad-tech names that sell programmatic inventory, since all of them are exposed to the same remedies in US v. Google ad tech. Its revenue follows the advertising cycle: Q4 is the seasonally largest quarter for programmatic spend, so a broad slowdown in ad budgets would hit the shares regardless of company-specific wins. As a small-cap, loss-making name trading near a 52-week high, it is more sensitive to swings in broad risk appetite than the S&P 500.